μ-Opioid receptor-stimulated guanosine-5'-O-(γ-thio)-triphosphate binding in rat thalamus and cultured cell lines: Signal transduction mechanisms underlying agonist efficacy

Molecular Pharmacology

Volumn 51, Issue 1, 1997, Pages 87-96

  Selley, Dana E ^a   Sim, Laura J ^a   Xiao, Ruoyo ^a   Liu, Qixu ^a   Childers, Steven R ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; FENTANYL; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); GUANOSINE DIPHOSPHATE; LEVALLORPHAN; MORPHINE; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR AGONIST; NALOXONE;

ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CHO CELL; CONTROLLED STUDY; DRUG EFFICACY; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY; RECEPTOR OCCUPANCY; SIGNAL TRANSDUCTION; THALAMUS;

EID: 0031017050     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.51.1.87     Document Type: Article

References (42)

1. Evans, C. J., D. E. Keith Jr., H. Morrison, K. Magendzo, and R. H. Edwards. Cloning of a delta opioid receptor by functional expression. Science (Washington D. C.) 258:1952-1955 (1992).
2. Kieffer, B. L., K. Befort, C. Gaveriaux-Ruff, and C. G. Hirth. The δ-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. Proc. Natl. Acad. Sci. USA 89:12048-12052 (1992).
3. Chen, Y., A. Mestek, J. Liu, and L. Yu. Molecular cloning of a rat κ opioid receptor reveals sequence similarities to the μ and δ opioid receptors. Biochem. J. 295:625-628 (1993).
4. Chen, Y., A. Mestek, J. Liu, J. A. Hurley, and L. Yu. Molecular cloning and functional expression of a μ-opioid receptor from rat brain. Mol. Pharmacol. 44:8-12 (1993).
5. Kenakin, T. Efficacy, in Pharmacologic Analysis of Drug-Receptor Interaction (T. Kenakin, ed.). Raven, New York, 249-277 (1993).
6. Burns, D. L., E. L. Hewlett, J. Moss, and M. Vaughan. Pertussis toxin inhibits enkephalin stimulation of GTPase of NG108-15 cells. J. Biol. Chem. 258:1435-1438 (1983).
7. Kurose, H., T. Katada, T. Amano, and M. Ui. Specific uncoupling by islet-activating, pertussis toxin, of negative signal transduction via α-adrenergic cholinergic, and opiate receptors in neuroblastoma X glioma hybrid cells. J. Biol. Chem. 258:4870-4875 (1983).
8. Childers, S. R. Opioid receptor-coupled second messengers. Life Sci. 48: 1991-2003 (1991).
9. North, R. A., J. T. Williams, A. Surprenant, and M. J. Christie, μ and δ receptors belong to a family of receptors that are coupled to potassium channels. Proc. Natl. Acad. Sci. USA 84:5487-5491 (1987).
10. 2-agonists in locus coeruleus neurons. Brain Res. 371:390-394 (1986).
11. o, regulates neuronal calcium channels. Nature (Lond.) 325:445-447 (1987).
12. Kleuss, C., J. Hescheler, C. Ewel, W. Rosenthal, G. Schultz, and B. Witig. Assignment of G-protein subtypes to specific receptors inducing inhibition of calcium currents. Nature (Lond.) 353:43-48 (1991).
13. Gilman, A. G. G proteins: transducers of receptor-generated signals. Annu. Rev. Biochem. 56:615-649 (1987).
14. Asano, T., S. E. Pedersen, C. W. Scott, and E. M. Ross. Reconstitution of catecholamine-stimulated binding of guanosine 5≪-O-(3-thiotriphosphate) to the stimulatory GTP-binding protein of adenylate cyclase. Biochemistry 23:5460-5467 (1984).
15. Gierschik, P., R. Moghtader, C. Straub, K. Dieterich, and K. H. Jakobs. Signal amplification in HL-60 granulocytes: evidence that the chemotactic peptide receptor catalytically activates guanine-nucleotide-binding regulatory proteins in native plasma membranes. Eur. J. Biochem. 197:725-732 (1991).
16. Sim, L. J., D. E. Selley, R. Xiao, and S. R. Childers. Differences in G-protein activation by mu and delta opioid, and cannabinoid, receptors in rat striatum. Eur. J. Pharmacol. 307:95-107 (1996).
17. Hilf, G., P. Gierschik, and K. H. Jakobs. Muscarinic acetylcholine receptor-stimulated binding of guanosine 5′-O-(3-thiotriphosphate) to guanine-nucleotide-binding proteins in cardiac membranes. Eur. J. Biochem. 186: 725-731 (1989).
18. 35S]thio) triphosphate binding. Mol. Pharmacol. 44:115-123 (1993).
19. 35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells. Mol. Pharmacol. 47:848-854 (1995).
20. Hutchinson, M., H. W. Kosterlitz, F. M. Leslie, A. A. Waterfield, and L. Terenius. Assessment in the guinea-pig ileum and mouse vas deferens of benzomorphans which have strong antinociceptive activity but do not substitute for morphine in the dependent monkey. Br. J. Pharmacol. 55:541-546 (1975).
21. Miller, L., J. S. Shaw, and E. M. Whiting. The contribution of intrinsic activity to the action of opioids in vitro. Br. J. Pharmacol. 87:595-601
22. France, C. P., L. R. Gerak, D. Flynn, G. D. Winger, F. Medzihradsky, J. R. Bagley, L. L. Brockunier, and J. J. Woods. Behavioral effects and receptor binding affinities of fentanyl derivatives in rhesus monkeys. J. Pharmacol. Exp. Ther. 274:17-28 (1995).
23. Mjanger, E., and T. L. Yaksh. Characteristics of dose-dependent antagonism by beta-funaltrexamine of the antinociceptive effects intrathecal mu agonists. J. Pharmacol. Exp. Ther. 258:544-550 (1991).
24. Saeki, S., and T. L. Yaksh. Suppression of nociceptive responses by spinal mu opioid agonists: effects of stimulus intensity and agonist efficacy. Anesth. Analg. 77:265-274 (1993).
25. Comer, S. D., T. F. Burke, J. W. Lewis, and J. H. Woods. Clocinnamox: a novel, systemically active, irreversible opioid antagonist. J. Pharmacol. Exp Ther. 262:1051-1056 (1992).
26. Zernig, G., E. R. Butelman, J. W. Lewis, E. A. Walker, and J. H. Woods. In vivo determination of mu opioid receptor turnover in rhesus monkeys after irreversible blockade with clocinnamox. J. Pharmacol. Exp. Ther. 269: 57-65 (1994).
27. Raffa, R. B., R. P. Martinez, and C. D. Connelly. G-protein antisense oligodeoxyribonucleotides and μ-opioid supraspinal antinociception. Eur. J. Pharmacol. 258:R5-R7 (1994).
28. Rossi, G., K. Standifer, and G. Pasternak. Differential blockade of morphine and morphine-6-beta-glucuronide analgesia by antisense oligodeoxynucleotides directed against MOR-1 and G-protein alpha subunits in rats. Neurosci, Lett, 198:(1995).
29. Herkenham, M., and C. B. Pert. Light microscopic localization of brain opiate receptors: a general autoradiographic method which preserves tissue quality. J. Neurosci. 2:1129-1149 (1982).
30. 35S]thio]-triphosphate binding. Proc. Natl. Acad. Sci. USA 92:7242-7246 (1995).
31. Yu, V. C., M. L. Richards, and W. Sadee. A human neuroblastoma cell line expresses μ and δ opioid receptor sites. J. Biol. Chem. 261:1065-1070 (1986).
32. 125I]β-endorphin binding to NG108-15 and SK-N-SH cell membranes: specific cation requirements. Brain Res. 493:23-32 (1989).
33. m GTPase studies. J. Pharmacol. Exp. Ther. 263:99-104 (1992).
34. Abood, M., M. Noel, R. Carter, and L. Harris. Evaluation of a series of N-alkyl benzomorphans in cell lines expressing transfected δ- and μ-opioid receptors. Biochem. Pharmacol. 50:851-859 (1995).
35. 34a.Kaufman, D. L., D. E. Keith, B. Anton, J. Tian, K. Magendzo, D. Newman, T. H. Tran, D. S. Lee, C. Wen, Y.-R. Xia, A. J. Lusis, and C. J. Evans. Characterization of the murine μ-opioid receptor gene. J. Biol. Chem. 280:15877-15883 (1995).
36. Bradford, M. M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254 (1976).
37. 35S]GTPγb autoradiography in rat brain. J. Neurosci. 16:2684-2692 (1996).
38. Moss, J. S.-C. Tsai, P. Bruni, R. Adamik, Y. Kanaho, E. L. Hewlett, and M. Vaughan. Pertussis toxin-catalyzed ADP-ribosylation of adenylate cyclase: effects of guanyl nucleotides and rhodopsin. Dev. Biol. Standard. 61:34-49 (1985).
39. 2+ and the βγ-subunit complex on the interactions of guanine nucleotides with G proteins. J. Biol. Chem. 262:762-766 (1987).
40. Liu-Chen, L.-Y., S. Li, H. Wheeler-Aceto, and A. Cowan. Effects of intracerebroventricular β-funaltrexamine on μ and δ opioid receptors in the rat: dichotomy between binding and antinociception. Eur. J. Pharmacol. 203: 195-202 (1991).
41. Christie, M. J., J. T. Williams, and R. A. North. Cellular mechanisms of opioid tolerance: studies in single brain neurons. Mol. Pharmacol. 32:633-638 (1987).
42. Yu, V. C., and W. Sadee. Efficacy and tolerance of narcotic analgesics at the mu opioid receptor in differentiated human neuroblastoma cells. J. Pharmacol. Exp. Ther. 245:350-355 (1988).